Trade Spotlight | What should you do with Gujarat State Petronet, Indoco Remedies, NLC India on Friday?
Indoco Remedies shares rallied more than 7 percent to Rs 415.35 and formed long bullish candle on the daily charts with strong volumes. Overall it has seen a good run up after breaking out long downward sloping resistance trend line adjoining August 12, 2021 and August 3, 2022.
INDOCO REMEDIES LTD. - 532612 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ('Listing Regulations')
Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions for the half year ended 30.09.2022.
Buy Indoco Remedies; target of Rs 465: ICICI Direct
ICICI Direct is bullish on Indoco Remedies recommended buy rating on the stock with a target price of Rs 465 in its research report dated November 13, 2022. INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing schedule for the Investor Call/ Institutional Investors Meetings. INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of analyst call held on 11th November, 2022 in respect of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2022.
Buy Indoco Remedies; target of Rs 430: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 430 in its research report dated November 14, 2022. INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Audio recording of Conference Call held on November 11, 2022 INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Un-Audited Financial Results for the Quarter and Half year ended 30th September, 2022 INDOCO REMEDIES LTD. - 532612 - Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Change in name of Key Managerial Personnel under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 INDOCO REMEDIES LTD. - 532612 - Appointment of Company Secretary and Compliance Officer
In compliance with the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company at their meeting held today i.e. 10th November, 2022 has inter-alia, considered and approved the following:- Based on the recommendation of the Nomination and Remuneration Committee and pursuant to Section 203 of the Companies Act, 2013 and Regulation 6(1) of the SEBI LODR Regulations, Mr. Ramanathan Hariharan (ICSI Membership No. A20593) is appointed as the Company Secretary and Compliance Officer of the Company w.e.f. 01st December, 2022